351 related articles for article (PubMed ID: 29482987)
21. The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.
Zhang X; Murray B; Mo G; Shern JF
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32182803
[TBL] [Abstract][Full Text] [Related]
22. Malignant peripheral nerve sheath tumor in children: A clinicopathologic and molecular study with parallels to the adult counterpart.
Agaram NP; Wexler LH; Chi P; Antonescu CR
Genes Chromosomes Cancer; 2023 Mar; 62(3):131-138. PubMed ID: 36414547
[TBL] [Abstract][Full Text] [Related]
23. Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors.
Pekmezci M; Cuevas-Ocampo AK; Perry A; Horvai AE
Mod Pathol; 2017 Dec; 30(12):1710-1719. PubMed ID: 28776579
[TBL] [Abstract][Full Text] [Related]
24. Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.
Sohier P; Luscan A; Lloyd A; Ashelford K; Laurendeau I; Briand-Suleau A; Vidaud D; Ortonne N; Pasmant E; Upadhyaya M
Genes Chromosomes Cancer; 2017 May; 56(5):421-426. PubMed ID: 28124441
[TBL] [Abstract][Full Text] [Related]
25. H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications.
Lu VM; Marek T; Gilder HE; Puffer RC; Raghunathan A; Spinner RJ; Daniels DJ
J Neurooncol; 2019 Sep; 144(3):433-443. PubMed ID: 31342317
[TBL] [Abstract][Full Text] [Related]
26.
Oppel F; Ki DH; Zimmerman MW; Ross KN; Tao T; Shi H; He S; Aster JC; Look AT
Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651197
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis.
Rekhi B; Kosemehmetoglu K; Tezel GG; Dervisoglu S
APMIS; 2017 Aug; 125(8):679-689. PubMed ID: 28452074
[TBL] [Abstract][Full Text] [Related]
28. The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers.
Mustapar N; Zawawi MSF; Tuan Sharif SE
Asian Pac J Cancer Prev; 2020 Mar; 21(3):699-705. PubMed ID: 32212796
[TBL] [Abstract][Full Text] [Related]
29. CDX2 expression in malignant peripheral nerve sheath tumour: a potential diagnostic pitfall associated with PRC2 inactivation.
Odeyemi OO; Ozawa MG; Charville GW
Histopathology; 2022 May; 80(6):995-1000. PubMed ID: 35122289
[TBL] [Abstract][Full Text] [Related]
30. Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.
Cortes-Ciriano I; Steele CD; Piculell K; Al-Ibraheemi A; Eulo V; Bui MM; Chatzipli A; Dickson BC; Borcherding DC; Feber A; Galor A; Hart J; Jones KB; Jordan JT; Kim RH; Lindsay D; Miller C; Nishida Y; Proszek PZ; Serrano J; Sundby RT; Szymanski JJ; Ullrich NJ; Viskochil D; Wang X; Snuderl M; Park PJ; Flanagan AM; Hirbe AC; Pillay N; Miller DT;
Cancer Discov; 2023 Mar; 13(3):654-671. PubMed ID: 36598417
[TBL] [Abstract][Full Text] [Related]
31. Radiation-associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation
Panse G; Mito JK; Ingram DR; Wani K; Khan S; Lazar AJ; Doyle LA; Wang WL
Histopathology; 2021 Jan; 78(2):321-326. PubMed ID: 32735735
[TBL] [Abstract][Full Text] [Related]
32. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state.
Kochat V; Raman AT; Landers SM; Tang M; Schulz J; Terranova C; Landry JP; Bhalla AD; Beird HC; Wu CC; Jiang Y; Mao X; Lazcano R; Gite S; Ingram DR; Yi M; Zhang J; Keung EZ; Scally CP; Roland CL; Hunt KK; Feig BW; Futreal PA; Hwu P; Wang WL; Lazar AJ; Slopis JM; Wilson-Robles H; Wiener DJ; McCutcheon IE; Wustefeld-Janssens B; Rai K; Torres KE
Acta Neuropathol; 2021 Sep; 142(3):565-590. PubMed ID: 34283254
[TBL] [Abstract][Full Text] [Related]
33. Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.
Korfhage J; Lombard DB
Mol Cancer Res; 2019 Jul; 17(7):1417-1428. PubMed ID: 31023785
[TBL] [Abstract][Full Text] [Related]
34. Low-Grade Malignant Peripheral Nerve Sheath Tumor Mimicking Schwannoma: Role and Importance of Trimethylated H3K27M Staining.
Gilder HE; Puffer RC; Spinner RJ; Raghunathan A; Bydon M
World Neurosurg; 2018 Sep; 117():178-181. PubMed ID: 29909207
[TBL] [Abstract][Full Text] [Related]
35. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas.
Plaat BE; Molenaar WM; Mastik MF; Hoekstra HJ; te Meerman GJ; van den Berg E
Int J Cancer; 1999 Oct; 83(2):171-8. PubMed ID: 10471523
[TBL] [Abstract][Full Text] [Related]
36. Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull base.
Makise N; Shimoi T; Sunami K; Aoyagi Y; Kobayashi H; Tanaka S; Kawai A; Yonemori K; Ushiku T; Yoshida A
Histopathology; 2023 Feb; 82(3):420-430. PubMed ID: 36217885
[TBL] [Abstract][Full Text] [Related]
37. [Malignant peripheral nerve sheath tumor: a clinicopathological analysis].
Peng W; Gong QX; Fan QH; Liu Y; Song GX; Wei YZ
Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):924-930. PubMed ID: 37670622
[No Abstract] [Full Text] [Related]
38. Update on Peripheral Nerve Sheath Tumors.
Martinez AP; Fritchie KJ
Surg Pathol Clin; 2019 Mar; 12(1):1-19. PubMed ID: 30709438
[TBL] [Abstract][Full Text] [Related]
39. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous epithelioid malignant peripheral nerve sheath tumour: a clinicopathological analysis of 11 cases.
Luzar B; Shanesmith R; Ramakrishnan R; Fisher C; Calonje E
Histopathology; 2016 Jan; 68(2):286-96. PubMed ID: 26096054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
